insights_auto
Why is RGEN up 2.08%?
Dive Deeperchevron_right
RGEN:NASDAQ
Repligen Corp
$180.10
arrow_upward
+2.08%(+3.67) 1D
Oct 20, 3:07:16 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RGEN...
Open
$176.50
High
$180.67
Low
$174.37
Mkt. cap
11.43B
Avg. vol.
1.21M
Volume
507.25K
P/E ratio
245.49
52-wk high
$198.86
52-wk low
$100.99
EPS
$0.73
Beta
1.08
Shares outstanding
63.49M
No. of employees
2K
Open
$176.50
High
$180.67
Low
$174.37
Mkt. cap
11.43B
Avg. vol.
1.21M
Volume
507.25K
P/E ratio
245.49
52-wk high
$198.86
52-wk low
$100.99
EPS
$0.73
Beta
1.08
Shares outstanding
63.49M
No. of employees
2K
News stories
From web sources and news partners
https://www.dars.gov.et/
·
1 week ago
RGEN Q2 2026 Earnings: An 18% EPS Beat That the Market Shrugged Off - Debt Analysis Report
Profile
Repligen Corporation is an American life sciences company that develops and manufactures products used in biological drug manufacturing. The company is headquartered in Waltham, Massachusetts, and is listed on the Nasdaq under the symbol RGEN. Wikipedia
About Repligen Corp
CEOTony J. Hunt
Employees2K
Founded1981
HeadquartersWaltham, Massachusetts, United States
SectorHealth care
Websiterepligen.com